Haloperidol Tablet
Product Images NDC 55154-5059

2 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Haloperidol (NDC 55154-5059). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4d9d027a 1ed4 4079 Ba74 A01380b0f0a2 00

4d9d027a 1ed4 4079 Ba74 A01380b0f0a2 00
Text panel for Haloperidol Tablets USP 5 mg, containing 10 tablets. The panel details that each tablet contains 5 mg haloperidol and includes storage instructions, a warning that the package is not child resistant, and distribution information. Manufactured by Mylan Pharmaceuticals Inc. and distributed by Cardinal Health.*
FDA Label Image

Structural Formula (B4a0c347 0c03 4cfc B6fd 79fc18bc85f4 01)

Structural Formula (B4a0c347 0c03 4cfc B6fd 79fc18bc85f4 01)
Chemical structure of haloperidol depicting its molecular components and arrangement as submitted in the product labeling.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.